Comments
Loading...
Immunome Earnings Estimates, EPS & Revenue | NASDAQ:IMNM | Benzinga
Immunome reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 11
EPS Estimate
$-0.500
Quarterly Revenue Estimate
$1.02M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$10.94M
Analyze the earnings history of Immunome using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMNM | Immunome | -$0.60 | -$0.50 | — | — | $2.36M | $1.02M | — | — | 08/11/2025 | Get Alert |
| IMNM | Immunome | -$2.51 | -$0.57 | -$0.52 | 8.77% | $1.03M | $457.14K | $2.93M | 540.07% | 05/12/2025 | Get Alert |
| IMNM | Immunome | -$0.15 | -$0.72 | -$1.28 | -77.78% | $3.83M | $3.07M | $2.74M | -10.81% | 03/19/2025 | Get Alert |
| IMNM | Immunome | -$0.36 | -$0.56 | -$0.78 | -39.29% | $3.56M | $2.13M | $2.91M | 36.62% | 11/13/2024 | Get Alert |
| IMNM | Immunome | -$0.46 | -$0.39 | -$0.60 | -53.85% | $4.26M | $2.55M | $2.36M | -7.29% | 08/12/2024 | Get Alert |
| IMNM | Immunome | -$0.35 | -$0.69 | -$0.34 | 50.72% | $2.36M | $2.50M | $1.03M | -58.84% | 05/14/2024 | Get Alert |
| IMNM | Immunome | -$0.64 | -$0.28 | -$0.15 | 46.43% | $0.00 | $2.07M | $3.83M | 84.83% | 03/28/2024 | Get Alert |
| IMNM | Immunome | -$0.75 | — | -$0.36 | — | $0.00 | — | $3.56M | — | 11/09/2023 | Get Alert |
| IMNM | Immunome | -$0.74 | -$0.16 | -$0.46 | -187.50% | $0.00 | — | $4.26M | — | 08/09/2023 | Get Alert |
| IMNM | Immunome | -$0.96 | $0.58 | -$0.35 | -160.34% | $0.00 | — | $2.36M | — | 05/05/2023 | Get Alert |
| IMNM | Immunome | -$0.65 | -$0.67 | -$0.64 | 4.48% | $0.00 | — | $0.00 | — | 03/16/2023 | Get Alert |
| IMNM | Immunome | -$0.65 | -$0.76 | -$0.75 | 1.32% | $0.00 | — | $0.00 | — | 11/14/2022 | Get Alert |
| IMNM | Immunome | -$0.46 | -$0.75 | -$0.74 | 1.33% | $0.00 | — | $0.00 | — | 08/05/2022 | Get Alert |
| IMNM | Immunome | -$0.37 | -$0.69 | -$0.96 | -39.13% | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| IMNM | Immunome | -$0.40 | -$0.81 | -$0.65 | 19.75% | $0.00 | — | $0.00 | — | 03/28/2022 | Get Alert |
| IMNM | Immunome | -$7.52 | -$0.81 | -$0.65 | 19.75% | $0.00 | — | $0.00 | — | 11/15/2021 | Get Alert |
| IMNM | Immunome | — | -$0.39 | -$0.46 | -17.95% | — | $3.80M | $0.00 | -100.00% | 08/16/2021 | Get Alert |
| IMNM | Immunome | -$2.44 | -$0.39 | -$0.37 | 5.13% | — | $3.80M | $0.00 | -100.00% | 05/12/2021 | Get Alert |
| IMNM | Immunome | — | — | -$0.40 | — | — | — | $0.00 | — | 03/25/2021 | Get Alert |
| IMNM | Immunome | -$2.50 | — | -$7.52 | — | — | — | $0.00 | — | 11/17/2020 | Get Alert |
Immunome (IMNM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $-0.52 | $-0.57 | 8.77 % |
| Q4 | 2025-03-19 | $-1.28 | $-0.72 | -77.8 % |
| Q3 | 2024-11-13 | $-0.78 | $-0.56 | -39.3 % |
| Q2 | 2024-08-12 | $-0.60 | $-0.39 | -53.8 % |
Immunome (IMNM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $2.93M | $457.14K | 540.1 % |
| Q4 | 2025-03-19 | $2.74M | $3.07M | -10.8 % |
| Q3 | 2024-11-13 | $2.91M | $2.13M | 36.6 % |
| Q2 | 2024-08-12 | $2.36M | $2.55M | -7.29 % |
FAQ
When is Immunome (NASDAQ:IMNM) reporting earnings?
Immunome (IMNM) is scheduled to report earnings on August 11, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.
What were the latest earnings per share (EPS) for Immunome (NASDAQ:IMNM)?
The Actual EPS was $-0.52, which beat the estimate of $-0.57.
What were Immunome’s (NASDAQ:IMNM) revenues?
The Actual Revenue was $2.9M, which beat the estimate of $457.1K.
Browse earnings estimates, EPS, and revenue on all stocks.
